As millions of people begin or continue GLP-1 therapy, a critical question has emerged in ophthalmology: what are these drugs doing to the eyes
Bad Stuff: These drugs didnt come without their problems, even before our shenanigans kicked off
Through a variety of mechanisms, metabolic syndrome increases our risk for cardiovascular disease, which can manifest as both acute and chronic blockages in the arteries supplying blood to our heart, strokes, heart rhythm abnormalities, and heart failure (weakness and stiffness of the heart muscle). The GLP1 [weight loss] drugs are the best available medications for treatment of obesity
Start your intake Pharmacology of GLP-1 in Breast Milk: What the Data Shows GLP-1 receptor agonists are large peptide molecules (semaglutide ~4,000 Da
doi:10.1016/j.aquatox.2021.105838
[PMC free article] [PubMed] [Google Scholar] 5.Lin Z, Fitzgerald JB, Xu J, Willers C, Wood D, Grodzinsky AJ, Zheng MH